StonvexLoading…
StonvexStonvexStonvexCore line items from EVGO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $109.53M | $384.09M | $265.62M | $173.32M |
Operating Income | $-36.35M | $-110.66M | $-98.30M | $-64.21M |
Net Income | $-16.42M | $-41.57M | $-36.74M | $-13.00M |
EPS (Diluted) | $-0.12 | $-0.31 | $-0.27 | $-0.18 |
Total Assets | $920.35M | $964.83M | $931.83M | $864.66M |
Total Liabilities | $567.68M | $578.89M | $542.61M | $464.08M |
Cash & Equivalents | $122.44M | $151.00M | $181.33M | $154.47M |
Free Cash Flow OCF − CapEx | $-65.94M | $-124.44M | $-86.33M | $-37.35M |
Shares Outstanding | 172.80M | 172.80M | 133.10M | 132.64M |